ABEONA THERAPEUTICS INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $0.00.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for the quarter ending 2024-06-30 was $3.50M, a 44.95% decline year-over-year.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for the quarter ending 2023-09-30 was $0.00.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for the quarter ending 2023-06-30 was $6.37M.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for fiscal 2021 was $8.05M.
- ABEONA THERAPEUTICS INC. stock issued during period, value, other for fiscal 2019 was $16.96M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2024-06-30 | $3.50M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | $6.37M 10-Q · filed 2024-08-12 | |
| 2021-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $8.05M 10-K · filed 2022-03-31 |
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.46M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $5.21M 10-Q · filed 2022-05-13 | |
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $16.96M 10-K · filed 2021-03-24 |
| 2019-09-30 | $4.34M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $12.62M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |